How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy

Lucia Taramasso, Federica Demma, Rossella Bitonti, Antonio Ferrazin, Barbara Giannini, Mauro Giacomini, Sabrina Beltramini, Elisabetta Sasso, Claudio Viscoli, Antonio Di Biagio

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The number of human immunodeficiency virus (HIV)-related hospitalizations has decreased worldwide in recent years, due to the availability of combined antiretroviral therapies (cART). The present analysis aimed to analyse the economic, and clinical burden of HIV management, after the introduction of systematic use of cART. Methods: Data from HIV-infected patients, treated at Policlinico San Martino Hospital in Genova (Italy) were retrospectively collected. A comparison between years 2009 and 2015 was performed. HIV-related admissions were identified by using the Diagnosis-Related Group (DRG) codes. The resource consumption of outpatient services was derived by using a modelling approach. Expenditure for drugs was also analysed, as aggregate data. Results: The number of HIV-infected patients was 898 in 2009 and 1006 in 2015. Overall, the virological success rate improved from 2009 to 2015, as the percentage of patients with HIV-RNA < 50 copies/mL increased from 79 to 89% (P < 0.05). The average incidence of hospitalizations per-patient decreased from 0.30 in 2009, to 0.13 in 2015. Average expenditure per-patient decreased from €10,107 in 2009 to €9063 in 2015. Conclusions: The present analysis confirmed the role of cART in controlling HIV viral load and, consequently, in reducing hospitalizations, admissions to day-hospital and the use of outpatient services. Clinical improvements and economic savings more than compensated the investments required to treat HIV-infected patients with cART. Health Authorities should invest in modern cART supply and universal treatment, to use at best the available resources and obtain a cost-effective improvement of health in people living with HIV. Additional research, with the involvement of different centers and the use of patient-specific data, are recommended to consolidate the findings of this analysis.

Original languageEnglish
Article number691
JournalBMC Health Services Research
Volume18
Issue number1
DOIs
Publication statusPublished - Sep 6 2018

Fingerprint

Italy
HIV
Databases
Costs and Cost Analysis
Hospitalization
Therapeutics
Ambulatory Care
Health Expenditures
Economics
Diagnosis-Related Groups
Health
Viral Load
RNA
Incidence
Research
Pharmaceutical Preparations

Keywords

  • AIDS
  • Antiretroviral
  • Burden
  • cART
  • Cost
  • HIV
  • Hospitalization

ASJC Scopus subject areas

  • Health Policy

Cite this

How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy. / Taramasso, Lucia; Demma, Federica; Bitonti, Rossella; Ferrazin, Antonio; Giannini, Barbara; Giacomini, Mauro; Beltramini, Sabrina; Sasso, Elisabetta; Viscoli, Claudio; Di Biagio, Antonio.

In: BMC Health Services Research, Vol. 18, No. 1, 691, 06.09.2018.

Research output: Contribution to journalArticle

Taramasso, L, Demma, F, Bitonti, R, Ferrazin, A, Giannini, B, Giacomini, M, Beltramini, S, Sasso, E, Viscoli, C & Di Biagio, A 2018, 'How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy', BMC Health Services Research, vol. 18, no. 1, 691. https://doi.org/10.1186/s12913-018-3507-x
Taramasso, Lucia ; Demma, Federica ; Bitonti, Rossella ; Ferrazin, Antonio ; Giannini, Barbara ; Giacomini, Mauro ; Beltramini, Sabrina ; Sasso, Elisabetta ; Viscoli, Claudio ; Di Biagio, Antonio. / How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy. In: BMC Health Services Research. 2018 ; Vol. 18, No. 1.
@article{e31a377192a6422e8bc01a95131d82cf,
title = "How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy",
abstract = "Background: The number of human immunodeficiency virus (HIV)-related hospitalizations has decreased worldwide in recent years, due to the availability of combined antiretroviral therapies (cART). The present analysis aimed to analyse the economic, and clinical burden of HIV management, after the introduction of systematic use of cART. Methods: Data from HIV-infected patients, treated at Policlinico San Martino Hospital in Genova (Italy) were retrospectively collected. A comparison between years 2009 and 2015 was performed. HIV-related admissions were identified by using the Diagnosis-Related Group (DRG) codes. The resource consumption of outpatient services was derived by using a modelling approach. Expenditure for drugs was also analysed, as aggregate data. Results: The number of HIV-infected patients was 898 in 2009 and 1006 in 2015. Overall, the virological success rate improved from 2009 to 2015, as the percentage of patients with HIV-RNA < 50 copies/mL increased from 79 to 89{\%} (P < 0.05). The average incidence of hospitalizations per-patient decreased from 0.30 in 2009, to 0.13 in 2015. Average expenditure per-patient decreased from €10,107 in 2009 to €9063 in 2015. Conclusions: The present analysis confirmed the role of cART in controlling HIV viral load and, consequently, in reducing hospitalizations, admissions to day-hospital and the use of outpatient services. Clinical improvements and economic savings more than compensated the investments required to treat HIV-infected patients with cART. Health Authorities should invest in modern cART supply and universal treatment, to use at best the available resources and obtain a cost-effective improvement of health in people living with HIV. Additional research, with the involvement of different centers and the use of patient-specific data, are recommended to consolidate the findings of this analysis.",
keywords = "AIDS, Antiretroviral, Burden, cART, Cost, HIV, Hospitalization",
author = "Lucia Taramasso and Federica Demma and Rossella Bitonti and Antonio Ferrazin and Barbara Giannini and Mauro Giacomini and Sabrina Beltramini and Elisabetta Sasso and Claudio Viscoli and {Di Biagio}, Antonio",
year = "2018",
month = "9",
day = "6",
doi = "10.1186/s12913-018-3507-x",
language = "English",
volume = "18",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy

AU - Taramasso, Lucia

AU - Demma, Federica

AU - Bitonti, Rossella

AU - Ferrazin, Antonio

AU - Giannini, Barbara

AU - Giacomini, Mauro

AU - Beltramini, Sabrina

AU - Sasso, Elisabetta

AU - Viscoli, Claudio

AU - Di Biagio, Antonio

PY - 2018/9/6

Y1 - 2018/9/6

N2 - Background: The number of human immunodeficiency virus (HIV)-related hospitalizations has decreased worldwide in recent years, due to the availability of combined antiretroviral therapies (cART). The present analysis aimed to analyse the economic, and clinical burden of HIV management, after the introduction of systematic use of cART. Methods: Data from HIV-infected patients, treated at Policlinico San Martino Hospital in Genova (Italy) were retrospectively collected. A comparison between years 2009 and 2015 was performed. HIV-related admissions were identified by using the Diagnosis-Related Group (DRG) codes. The resource consumption of outpatient services was derived by using a modelling approach. Expenditure for drugs was also analysed, as aggregate data. Results: The number of HIV-infected patients was 898 in 2009 and 1006 in 2015. Overall, the virological success rate improved from 2009 to 2015, as the percentage of patients with HIV-RNA < 50 copies/mL increased from 79 to 89% (P < 0.05). The average incidence of hospitalizations per-patient decreased from 0.30 in 2009, to 0.13 in 2015. Average expenditure per-patient decreased from €10,107 in 2009 to €9063 in 2015. Conclusions: The present analysis confirmed the role of cART in controlling HIV viral load and, consequently, in reducing hospitalizations, admissions to day-hospital and the use of outpatient services. Clinical improvements and economic savings more than compensated the investments required to treat HIV-infected patients with cART. Health Authorities should invest in modern cART supply and universal treatment, to use at best the available resources and obtain a cost-effective improvement of health in people living with HIV. Additional research, with the involvement of different centers and the use of patient-specific data, are recommended to consolidate the findings of this analysis.

AB - Background: The number of human immunodeficiency virus (HIV)-related hospitalizations has decreased worldwide in recent years, due to the availability of combined antiretroviral therapies (cART). The present analysis aimed to analyse the economic, and clinical burden of HIV management, after the introduction of systematic use of cART. Methods: Data from HIV-infected patients, treated at Policlinico San Martino Hospital in Genova (Italy) were retrospectively collected. A comparison between years 2009 and 2015 was performed. HIV-related admissions were identified by using the Diagnosis-Related Group (DRG) codes. The resource consumption of outpatient services was derived by using a modelling approach. Expenditure for drugs was also analysed, as aggregate data. Results: The number of HIV-infected patients was 898 in 2009 and 1006 in 2015. Overall, the virological success rate improved from 2009 to 2015, as the percentage of patients with HIV-RNA < 50 copies/mL increased from 79 to 89% (P < 0.05). The average incidence of hospitalizations per-patient decreased from 0.30 in 2009, to 0.13 in 2015. Average expenditure per-patient decreased from €10,107 in 2009 to €9063 in 2015. Conclusions: The present analysis confirmed the role of cART in controlling HIV viral load and, consequently, in reducing hospitalizations, admissions to day-hospital and the use of outpatient services. Clinical improvements and economic savings more than compensated the investments required to treat HIV-infected patients with cART. Health Authorities should invest in modern cART supply and universal treatment, to use at best the available resources and obtain a cost-effective improvement of health in people living with HIV. Additional research, with the involvement of different centers and the use of patient-specific data, are recommended to consolidate the findings of this analysis.

KW - AIDS

KW - Antiretroviral

KW - Burden

KW - cART

KW - Cost

KW - HIV

KW - Hospitalization

UR - http://www.scopus.com/inward/record.url?scp=85053050823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053050823&partnerID=8YFLogxK

U2 - 10.1186/s12913-018-3507-x

DO - 10.1186/s12913-018-3507-x

M3 - Article

AN - SCOPUS:85053050823

VL - 18

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 691

ER -